Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors First once-weekly subcutaneous prophylactic option for hemophilia B Oct 11, 2024
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing? Debate highlights pros and cons of the new recommendation Oct 11, 2024
Study Details Perinatal Risks of Blood Cancers Diagnosed in Pregnancy Likelihood of severe maternal morbidity more than 20 times higher versus the general population Oct 11, 2024
Kate Middleton's Post-Chemo Debut; CDC Probes Cancer Cluster; 15M Adults Have ADHD Health news and commentary gathered by MedPage Today staff Oct 11, 2024
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease Oct 10, 2024
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone Oct 10, 2024
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging? News, features, and commentary about cancer-related issues Oct 10, 2024
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity Differences in absolute, relative risk highlight complexities of analyzing rare events Oct 09, 2024
'The Office' Star Has Cancer; Trump Sent COVID Tests to Putin? 3% of Teens Are Trans Health news and commentary gathered by MedPage Today staff Oct 09, 2024
Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in Melanoma Two-year survival in second line for patients with BRAF/NRAS wild-type tumors Oct 08, 2024
Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolism Study raises questions about how to assess patient risk, experts say Oct 08, 2024
Hormonal Contraception Linked to Increased Breast Cancer Risk in BRCA1 Carriers Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers Oct 07, 2024
Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma High overall response rate, even though many were ineligible for trial leading to drug's approval Oct 04, 2024
EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk Substantial drops in cancer-specific mortality affirmed in Chinese trial Oct 04, 2024
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer News, features, and commentary about cancer-related issues Oct 04, 2024
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group Rates rose after USPSTF recommendation, but increase was uneven Oct 03, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Where Are Trump's Medical Records? New Sunscreen Under Review; Why Condoms Are Nixed Health news and commentary gathered by MedPage Today staff Oct 03, 2024
'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma Small study suggests large benefit for Lu-177 dotatate in intracranial disease Oct 02, 2024
Can HPV Self-Tests Truly Replace Pap Smears? Many patients may prefer a self-collected swab over a speculum Oct 02, 2024
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC Latest negative results emphasize "critical" aspect of immunotherapy timing Oct 02, 2024
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer With 98% PFS at 2 years, standard RT plus cisplatin sets a higher bar for de-escalation Oct 02, 2024
Trump Vows to Veto Abortion Ban; Breast Cancer Climbs; Diagnostic Errors for 1 in 14 Health news and commentary gathered by MedPage Today staff Oct 02, 2024
More Evidence Favors a Shorter Course of Post-Mastectomy RT Trial finds similar complication and recurrence rates with hypofractionated versus standard RT Oct 01, 2024
No Improvement in Lymphedema With Hypofractionated Nodal RT for Breast Cancer Numerical advantage in randomized trial, non-randomized study misses noninferiority mark Oct 01, 2024
VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets Health news and commentary gathered by MedPage Today staff Oct 01, 2024
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer "It really shows us that we have two great options," expert says Sep 30, 2024
H. Pylori Testing Did Not Reduce Gastric Cancer Incidence, Mortality Gastric cancer incidence was lower after adjusting for certain factors in post hoc analyses Sep 30, 2024
Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Risk Also in TTHealthWatch: AACR report on cancer Sep 28, 2024 podcast
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1 Sep 27, 2024
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer An increase in microbial risk score based on 22 bacteria tied to a 50% increase in HNSCC risk Sep 27, 2024
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients Study suggests differences in how the ACA cost-sharing exemption is applied across patient groups Sep 27, 2024 video
Timely Skin Cancer Screening After Organ Transplant Still Lacking Only a minority of patients adhered to SUNTRAC screening recommendations Sep 26, 2024
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement News, features, and commentary about cancer-related issues Sep 26, 2024
GOP Doctor Vying for House Seat in Kansas Air Force, Harvard Business School, clinical practice all part of Prasanth Reddy's resume Sep 26, 2024
Sickle Cell Disease Drug Pulled From Global Markets Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
FDA Expands Approval of Osimertinib in Lung Cancer EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic Actual rates for 2021 lagged behind projections Sep 25, 2024
